NCT06035588

Brief Summary

The concentration of 16% carbamide peroxide is the highest concentration that European regulations allow for use in home whitening (Council directive 2011/84/EU). This concentration allows for faster results, but instead patients may suffer more frequently from dental sensitivity. The most commonly described side effect of all whitening procedures is the appearance of dentin hypersensitivity, hence the efforts to counteract or overcome this adverse effect. The objective of the study is to clinically evaluate the difference in dental hypersensitivity produced by home dental whitening treatment using 16% carbamide peroxide in a tray for two hours daily applied daily or every other day for three weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 6, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.1 years

First QC Date

September 6, 2023

Last Update Submit

September 28, 2025

Conditions

Keywords

bleachinghipersensitivitywhiteningat-homecarbamide

Outcome Measures

Primary Outcomes (1)

  • Dental Sensitivity Visual Analog Scale (VAS) 0-10

    The aim of this study is to clinically evaluate the incidence of tooth sensitivity induced by home whitening with 16% carbamide peroxide applied in a tray for two hours daily or every other day for three weeks. For the assessment, the operators will apply air to the cervical area of the upper and lower canines and ask the patient if he/she experienced sensitivity at any time during the treatment.

    3 weeks

Secondary Outcomes (1)

  • Whitening Efficacy CIEL*a*b*

    1 month

Other Outcomes (2)

  • Gingival irritation VAS (0-10)

    3 weeks

  • Patient's oral quality of life (OHIP-14)

    1 month

Study Arms (2)

Daily whitening

ACTIVE COMPARATOR

Volunteers should whiten daily with a whitening tray from 15 to 25 and 35 to 45 for 2 hours. This procedure will last 3 weeks.

Other: Daily whitening

Alternate whitening

EXPERIMENTAL

Volunteers will bleach for 3 weeks with 16% carbamide peroxide, alternating one rest day for each placement day. They will wear a whitening tray from 15 to 25 and from 35 to 45 for 2 hours.

Other: Alternate whitening

Interventions

Daily application of a 16% carbamide peroxide bleaching gel in volunteers without sensitivity.

Daily whitening

Volunteers will apply the whitening gel at 16% carbamide peroxide, alternating a rest day with an application day. Patients should not be sensitive before starting the study.

Alternate whitening

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years.
  • Patients with vital teeth without restorations, single crowns, implants and/or bridges at the level of the anterior teeth.
  • Absence of cavities in the teeth to be whitened.
  • Patients with satisfactory oral hygiene and periodontally healthy, who are not undergoing periodontal maintenance and who do not use chlorhexidine mouthwashes. Patients with recessions without presenting sensitivity will be included.
  • Absence of sensitivity, measured with the application of air with the dental team's syringe.
  • Patients whose canines have at least an A2-A3 shade (VITA Classic® Guide).

You may not qualify if:

  • Patients who have previously undergone whitening (less than 5 years).
  • Patients undergoing orthodontic treatment.
  • Patients with white spots or alterations in the development of enamel or with stains.
  • Patients with a history of trauma to anterior teeth.
  • Patients who require internal whitening.
  • Smokers.
  • Pregnant or lactating.
  • Patients with allergies to any whitening component.
  • Patients presenting alterations of the oral mucosa (desquamative gingivitis, oral lichen planus, leukoplakia, etc.).
  • Patients with medical conditions considered by the researchers that may compromise the study or the individual safety of the patient.
  • Patients with poor oral hygiene.
  • Patients with previous hypersensitivity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Isabel Giraldez de Luis

Alcorcón, Madrid, 28922, Spain

Location

Related Publications (3)

  • Cardoso PC, Reis A, Loguercio A, Vieira LC, Baratieri LN. Clinical effectiveness and tooth sensitivity associated with different bleaching times for a 10 percent carbamide peroxide gel. J Am Dent Assoc. 2010 Oct;141(10):1213-20. doi: 10.14219/jada.archive.2010.0048.

    PMID: 20884923BACKGROUND
  • Chagas AS, Freitas KMS, Cancado RH, Valarelli FP, Canuto LFG, Oliveira RCG, Oliveira RCG. Level of satisfaction in the use of the wraparound Hawley and thermoplastic maxillary retainers. Angle Orthod. 2020 Jan;90(1):63-68. doi: 10.2319/031319-197.1. Epub 2019 Jul 22.

    PMID: 31335161BACKGROUND
  • de Geus JL, Wambier LM, Boing TF, Loguercio AD, Reis A. At-home Bleaching With 10% vs More Concentrated Carbamide Peroxide Gels: A Systematic Review and Meta-analysis. Oper Dent. 2018 Jul/Aug;43(4):E210-E222. doi: 10.2341/17-222-L.

    PMID: 29949477BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The present study presents blinding of both the evaluator and the person who will carry out the statistical analysis, and therefore double-blind. The evaluators are considered blind in this study because they do not know the randomization of the patients, being a blind study. The operator and patients know the groups in which they are assigned, due to the delivery and placement of the splints. A block randomization of the treatment applied to the patients will be carried out, to ensure that the sample size is similar in both groups. The operator will open an envelope for the group's allocation. The assignment of the groups will be carried out using opaque, sealed and sequentially numbered envelopes. The operator will open the envelope when the splints are delivered, and will give the pertinent explanations to the patient. Data will be collected from each patient that may influence treatment results such as age, sex, initial color, systemic pathologies and pharmacological treatments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Each volunteer will be given 3 syringes of 16% carbamide peroxide bleaching gel to use on the splint. Volunteers will be instructed to use the whitening gel once a day for 2 hours, completing a total of 3 weeks of whitening procedure. Depending on the randomization, the whitening procedure will be performed on alternate days or daily. In the upper arch, the teeth to be whitened will be from 15 to 25 and in the lower one from 35 to 45.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Department for Conservative Dentistry at Rey Juan Carlos University

Study Record Dates

First Submitted

September 6, 2023

First Posted

September 13, 2023

Study Start

January 6, 2024

Primary Completion

February 27, 2025

Study Completion

September 1, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The results obtained will only be shared once they have been published in an impact journal.

Locations